INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 14 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $74,000 | +5.7% | 25,882 | -22.7% | 0.00% | 0.0% |
Q3 2016 | $70,000 | +204.3% | 33,485 | +128.8% | 0.00% | – |
Q2 2016 | $23,000 | -68.9% | 14,638 | -41.7% | 0.00% | -100.0% |
Q2 2015 | $74,000 | -16.9% | 25,119 | -36.4% | 0.00% | 0.0% |
Q4 2014 | $89,000 | -25.8% | 39,482 | +21.0% | 0.00% | 0.0% |
Q4 2013 | $120,000 | +263.6% | 32,621 | +94.1% | 0.00% | – |
Q3 2013 | $33,000 | – | 16,809 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 72,787 | $219,000 | 0.22% |
Tekla Capital Management LLC | 1,404,000 | $4,226,000 | 0.20% |
FIRST MIDWEST BANK TRUST DIVISION | 49,372 | $149,000 | 0.02% |
Tower Research Capital LLC (TRC) | 13,287 | $40,000 | 0.00% |
A.R.T. Advisors, LLC | 17,910 | $53,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 12,000 | $36,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 25 | $0 | 0.00% |
AMERIPRISE FINANCIAL INC | 30,000 | $90,000 | 0.00% |
1832 Asset Management L.P. | 12 | $0 | 0.00% |
DEUTSCHE BANK AG\ | 192,676 | $579,000 | 0.00% |